Cite
Freyn AW, Pine M, Rosado VC, et al. Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Mol Ther Methods Clin Dev. 2021;22:84-95doi: 10.1016/j.omtm.2021.06.003.
Freyn, A. W., Pine, M., Rosado, V. C., Benz, M., Muramatsu, H., Beattie, M., Tam, Y. K., Krammer, F., Palese, P., Nachbagauer, R., McMahon, M., & Pardi, N. (2021). Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Molecular therapy. Methods & clinical development, 2284-95. https://doi.org/10.1016/j.omtm.2021.06.003
Freyn, Alec W, et al. "Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice." Molecular therapy. Methods & clinical development vol. 22 (2021): 84-95. doi: https://doi.org/10.1016/j.omtm.2021.06.003
Freyn AW, Pine M, Rosado VC, Benz M, Muramatsu H, Beattie M, Tam YK, Krammer F, Palese P, Nachbagauer R, McMahon M, Pardi N. Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice. Mol Ther Methods Clin Dev. 2021 Jun 12;22:84-95. doi: 10.1016/j.omtm.2021.06.003. eCollection 2021 Sep 10. PMID: 34485597; PMCID: PMC8390451.
Copy
Download .nbib